癌细胞
细胞毒性
蛋白质降解
蛋白酶体
化学
蛋白质水解
细胞生物学
细胞毒性T细胞
生物化学
癌症研究
生物
分子生物学
癌症
酶
体外
遗传学
作者
Dehao Yu,Heli Fan,Zhili Zhou,Ying Zhang,Jing Sun,Luo Wang,Yuanyuan Jia,Junyu Tian,Anahit Campbell,Wenyi Mi,Huabing Sun
出处
期刊:ChemBioChem
[Wiley]
日期:2023-07-18
卷期号:24 (17)
被引量:6
标识
DOI:10.1002/cbic.202300422
摘要
Abstract Proteolysis‐targeting chimeras (PROTACs) provide a powerful technique to degrade targeted proteins utilizing the cellular ubiquitin‐proteasome system. The major concern is the host toxicity resulting from their poor selectivity. Inducible PROTACs responding to exogenous stimulus, such as light, improve their specificity, but it is difficult for photo‐activation in deep tissues. Herein, we develop H 2 O 2 ‐inducible PROTAC precursors 2 / 5 , which can be activated by endogenous H 2 O 2 in cancer cells to release the active PROTACs 1 / 4 to effectively degrade targeted proteins. This results in the intended cytotoxicity towards cancer cells while targeted protein in normal cells remains almost unaffected. The higher Bromodomain‐containing protein 4 (BRD4) degradation activity and cytotoxicity of 2 towards cancer cells is mainly due to the higher endogenous concentration of H 2 O 2 in cancer cells (A549 and H1299), characterized by H 2 O 2 ‐responsive fluorescence probe 3 . Western blot assays and cytotoxicity experiments demonstrate that 2 degrades BRD4 more effectively and is more cytotoxic in H 2 O 2 ‐rich cancer cells than in H 2 O 2 ‐deficient normal cells. This method is also extended to estrogen receptor (ER)‐PROTAC precursor 5 , showing H 2 O 2 ‐dependent ER degradation ability. Thus, we establish a novel strategy to induce targeted protein degradation in a H 2 O 2 ‐dependent way, which has the potential to improve the selectivity of PROTACs.
科研通智能强力驱动
Strongly Powered by AbleSci AI